4//SEC Filing
Oliver Tracie 4
Accession 0001628280-24-000867
CIK 0000879407other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 5:17 PM ET
Size
7.0 KB
Accession
0001628280-24-000867
Insider Transaction Report
Form 4
Oliver Tracie
Chief Commercial Officer
Transactions
- Sale
Common Stock
2024-01-05$33.89/sh−74$2,508→ 136,501 total - Award
Common Stock
2024-01-04+75,000→ 136,575 total
Footnotes (4)
- [F1]Represents shares underlying restricted stock units with a grant date 01/04/24, which will vest in four equal annual installments.
- [F2]Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F3]Partial disposition of RSUs to satisfy tax withholding obligations.
- [F4]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001935706
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 5:17 PM ET
- Size
- 7.0 KB